American Oncology Network Inc. Net Assets
American Oncology Network Inc. net assets. Based on the latest financial reports, American Oncology Network Inc. (AONC) has net assets worth $108.01 Million USD as of December 2024. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($470.33 Million) and total liabilities ($362.32 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. See American Oncology Network Inc. (AONC) net asset quality to measure how much of total assets are equity-financed.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $108.01 Million |
| % of Total Assets | 22.96% |
| Annual Growth Rate | 717.64% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 404984.53 |
Net Assets of American Oncology Network Inc. (2020–2024)
Net assets of American Oncology Network Inc. from 2020 to 2024. This chart illustrates how American Oncology Network Inc.'s net assets have evolved over time, based on quarterly financial data. Also explore net asset growth rate of American Oncology Network Inc. to track the company's year-over-year net asset growth rate.
Annual Net Assets for American Oncology Network Inc. (2020–2024)
The table below shows the annual net assets of American Oncology Network Inc. from 2020 to 2024. For live market cap and overall valuation, see how much is American Oncology Network Inc. worth.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $108.01 Million | +52.74% |
| 2023-12-31 | $70.71 Million | +14.02% |
| 2022-12-31 | $62.02 Million | -72.56% |
| 2021-12-31 | $226.04 Million | +935269.76% |
| 2020-12-31 | $24.17K | -- |
Equity Component Analysis
This analysis shows how different components contribute to American Oncology Network Inc.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 10217016600.0% over the analyzed period, potentially due to dividend distributions or operating losses.
American Oncology Network Inc. Net Assets Breakdown (December 2024)
American Oncology Network Inc. net assets breakdown by equity component as of December 2024.
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $4.00K | 0.02% |
| Other Comprehensive Income | $28.00K | 0.15% |
| Other Components | $120.91 Million | 644.13% |
| Total Equity | $18.77 Million | 100.00% |
American Oncology Network Inc. Competitors by Market Cap
The table below lists competitors of American Oncology Network Inc. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Shenwu Energy Saving Co Ltd
SHE:000820
|
$325.46 Million |
|
Lucky Strike Entertainment Corporation
NYSE:LUCK
|
$325.47 Million |
|
Development Investment Construction JSC
VN:DIG
|
$325.56 Million |
|
LINKBANCORP Inc
NASDAQ:LNKB
|
$325.59 Million |
|
Beihai Gofar Marine Biological Industry Co Ltd
SHG:600538
|
$325.24 Million |
|
Deva Holding AS
IS:DEVA
|
$325.02 Million |
|
New Providence Acquisition Corp. III Class A Ordinary Shares
NASDAQ:NPAC
|
$324.93 Million |
|
Stalprodukt SA
WAR:STP
|
$324.93 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in American Oncology Network Inc.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -161,727,000 to 18,771,000, a change of 180,498,000.
- Net loss of 3,973,000 reduced equity.
- Share repurchases of 368,000 reduced equity.
- New share issuances of 50,000,000 increased equity.
- Other comprehensive income decreased equity by 53,000.
- Other factors increased equity by 134,892,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-3.97 Million | -21.17% |
| Share Repurchases | $368.00K | -1.96% |
| Share Issuances | $50.00 Million | +266.37% |
| Other Comprehensive Income | $-53.00K | -0.28% |
| Other Changes | $134.89 Million | +718.62% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares American Oncology Network Inc.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 7.99x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 13740.56x to 7.99x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-12-31 | $0.00 | $11.12 | x |
| 2021-12-31 | $7.50 | $11.12 | x |
| 2022-12-31 | $1.49 | $11.12 | x |
| 2023-12-31 | $-24.19 | $11.12 | x |
| 2024-12-31 | $1.39 | $11.12 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently American Oncology Network Inc. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -21.17%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -0.23%
- • Asset Turnover: 3.74x
- • Equity Multiplier: 25.06x
- Recent ROE (-21.17%) is below the historical average (18163.44%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | 90834.23% | 3.03% | 14780.12x | 2.03x | $21.95 Million |
| 2021 | -0.03% | -0.01% | 3.80x | 0.79x | $-31.37 Million |
| 2022 | 4.17% | 0.23% | 3.52x | 5.26x | $-3.61 Million |
| 2023 | 0.00% | -0.43% | 3.42x | 0.00x | $10.63 Million |
| 2024 | -21.17% | -0.23% | 3.74x | 25.06x | $-5.85 Million |
Industry Comparison
This section compares American Oncology Network Inc.'s net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $516,527,000
- Average return on equity (ROE) among peers: -43.84%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| American Oncology Network Inc. (AONC) | $108.01 Million | 90834.23% | 3.35x | $325.24 Million |
| Acadia Healthcare Company Inc (ACHC) | $2.33 Billion | -7.53% | 1.65x | $1.52 Billion |
| Addus HomeCare Corporation (ADUS) | $275.53 Million | 6.35% | 0.29x | $1.69 Billion |
| agilon health Inc (AGL) | $126.73 Million | -319.84% | 9.03x | $1.51 Billion |
| Airsculpt Technologies Inc (AIRS) | $79.29 Million | -10.41% | 1.65x | $86.51 Million |
| Amedisys Inc (AMED) | $879.72 Million | 12.80% | 0.48x | $3.32 Billion |
| AMN Healthcare Services Inc (AMN) | $170.84 Million | -71.51% | 1.28x | $624.22 Million |
| American Shared Hospital Service (AMS) | $23.04 Million | 0.25% | 1.84x | $8.87 Million |
| Ardent Health Partners, Inc. (ARDT) | $760.28 Million | -4.69% | 2.12x | $1.66 Billion |
| Astrana Health Inc (ASTH) | $0.00 | 0.00% | 0.00x | $1.86 Billion |
About American Oncology Network Inc.
American Oncology Network, Inc., through its subsidiaries, provides oncology management services in the United States. The company provides various services to patients, including laboratory services for routine and specialized testing; in-house professional and technical pathology services with pathology reports; in-house specialty pharmacy services with patient education, financial assistance, … Read more